Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Highlights: GLP-1 users had a 37% higher hair loss risk than SGLT-2 inhibitor users, although the overall risk remained low Most cases involved temporary, non-scarring hair loss linked to rapid weight loss and nutritional changes Experts recommend maintaining good nutrition and consulting a doctor rather than stopping GLP-1 treatment Weight loss drugs called GLP-1 receptor agonists, including Ozempic, Wegovy, Mounjaro, and Zepbound, are transforming the treatment of obesity and type 2 diabetes by improving blood sugar control and promoting substantial weight loss
Most of this weight loss occurs within the first 68 to 72 weeks of treatment, so patience and consistency are key
Disclaimer: This article provides general information on an as is basis without any warranty of any kind
Nutrition priorities: Consider working with a dietitian to ensure adequate micronutrient intake
Jan 2018;35(1):25-39
Cardiometabolic Effects : Retatrutide has shown promising effects on various cardiometabolic parameters
US$ 21.24
US$ 20.12
US$ 27.56
US$ 26.35
US$ 29.29
US$ 22.89
US$ 22.41
